ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up

被引:856
作者
Colombo, N. [1 ,2 ]
Creutzberg, C. [3 ]
Amant, F. [4 ,5 ]
Bosse, T. [6 ]
Gonzalez-Martin, A. [7 ,8 ]
Ledermann, J. [9 ]
Marth, C. [10 ]
Nout, R. [11 ]
Querleu, D. [12 ,13 ]
Mirza, M. R. [14 ]
Sessa, C. [15 ]
机构
[1] European Inst Oncol, Div Med Gynecol Oncol, Milan, Italy
[2] Univ Milano Bicocca, Milan, Italy
[3] Leiden Univ, Dept Radiat Oncol, Med Ctr, Leiden, Netherlands
[4] Univ Hosp Leuven, Dept Gynecol Oncol, Leuven, Belgium
[5] Ctr Gynecol Oncol Amsterdam, Amsterdam, Netherlands
[6] Leiden Univ, Dept Pathol, Med Ctr, Leiden, Netherlands
[7] GEICO Canc Ctr, Dept Med Oncol, Madrid, Spain
[8] MD Anderson Canc Ctr, Dept Med Oncol, Madrid, Spain
[9] UCL Canc Inst, Dept Oncol & Canc Trials, London, England
[10] Med Univ Innsbruck, Dept Obstet & Gynecol, A-6020 Innsbruck, Austria
[11] Leiden Univ, Dept Radiotherapy, Med Ctr, Leiden, Netherlands
[12] Inst Bergonie, Dept Surg, Bordeaux, France
[13] McGill Univ, Dept Obstet & Gynecol, Ctr Hlth, Montreal, PQ H3A 2T5, Canada
[14] Copenhagen Univ Hosp, Rigshosp, Dept Oncol, Copenhagen, Denmark
[15] Osped San Giovanni Bellinzona, Oncol Inst Southern Switzerland, Dept Med Oncol, Bellinzona, Switzerland
关键词
endometrial neoplasms; practice guideline; consensus; treatment; adjuvant; surgery; PHASE-III TRIAL; LYMPHVASCULAR SPACE INVOLVEMENT; FERTILITY-SPARING-MANAGEMENT; POSTOPERATIVE RADIATION-THERAPY; WHOLE-ABDOMINAL-IRRADIATION; EXTERNAL-BEAM RADIOTHERAPY; UTERINE SEROUS CARCINOMA; INDEPENDENT RISK-FACTOR; CLINICAL STAGE-I; CLEAR-CELL;
D O I
10.1093/annonc/mdv484
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The first joint European Society for Medical Oncology (ESMO), European SocieTy for Radiotherapy & Oncology (ESTRO) and European Society of Gynaecological Oncology (ESGO) consensus conference on endometrial cancer was held on 11-13 December 2014 in Milan, Italy, and comprised a multidisciplinary panel of 40 leading experts in the management of endometrial cancer. Before the conference, the expert panel prepared three clinically relevant questions about endometrial cancer relating to the following four areas: prevention and screening, surgery, adjuvant treatment and advanced and recurrent disease. All relevant scientific literature, as identified by the experts, was reviewed in advance. During the consensus conference, the panel developed recommendations for each specific question and a consensus was reached. Results of this consensus conference, together with a summary of evidence supporting each recommendation, are detailed in this article. All participants have approved this final article.
引用
收藏
页码:16 / 41
页数:26
相关论文
共 213 条
  • [11] American College of Obstetricians and Gynecologists, 2005, Obstet Gynecol, V106, P413
  • [12] [Anonymous], 2014, Obstet Gynecol, V123, P1394, DOI 10.1097/01.AOG.0000450757.18294.cf
  • [13] [Anonymous], 2012, Globocan 2012: Estimated cancer incidence, mortality and prevalence worldwide in 2012
  • [14] HE4 and CA125 levels in the preoperative assessment of endometrial cancer patients: a prospective multicenter study (ENDOMET)
    Antonsen, Sofie L.
    Hogdall, Estrid
    Christensen, Ib J.
    Lydolph, Magnus
    Tabor, Ann
    Jakobsen, Annika Loft
    Fago-Olsen, Carsten L.
    Andersen, Erik S.
    Jochumsen, Kirsten
    Hogdall, Claus
    [J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2013, 92 (11) : 1313 - 1322
  • [15] Clinically Occult Tubal and Ovarian High-grade Serous Carcinomas Presenting in Uterine Samples: Diagnostic Pitfalls and Clues to Improve Recognition of Tumor Origin
    Bagby, Christina
    Ronnett, Brigitte M.
    Yemelyanova, Anna
    Maleki, Zahra
    Kuhn, Elisabetta
    Vang, Russell
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2013, 32 (05) : 433 - 443
  • [16] Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage endometrial cancer: a prospective multicentre study (SENTI-ENDO)
    Ballester, Marcos
    Dubernard, Gil
    Lecuru, Fabrice
    Heitz, Denis
    Mathevet, Patrice
    Marret, Henri
    Querleu, Denis
    Golfier, Francois
    Leblanc, Eric
    Rouzier, Roman
    Darai, Emile
    [J]. LANCET ONCOLOGY, 2011, 12 (05) : 469 - 476
  • [17] Cytoreductive surgery for advanced or recurrent endometrial cancer: A meta-analysis
    Barlin, Joyce N.
    Puri, Isha
    Bristow, Robert E.
    [J]. GYNECOLOGIC ONCOLOGY, 2010, 118 (01) : 14 - 18
  • [18] The Role of Vaginal Brachytherapy in the Treatment of Surgical Stage I Papillary Serous or Clear Cell Endometrial Cancer
    Barney, Brandon M.
    Petersen, Ivy A.
    Mariani, Andrea
    Dowdy, Sean C.
    Bakkum-Gamez, Jamie N.
    Haddock, Michael G.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 85 (01): : 109 - 115
  • [19] Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis
    Barry, John A.
    Azizia, Mallika M.
    Hardiman, Paul J.
    [J]. HUMAN REPRODUCTION UPDATE, 2014, 20 (05) : 748 - 758
  • [20] A clue towards improving the European Society of Medical Oncology risk group classification in apparent early stage endometrial cancer? Impact of lymphovascular space invasion
    Bendifallah, S.
    Canlorbe, G.
    Raimond, E.
    Hudry, D.
    Coutant, C.
    Graesslin, O.
    Touboul, C.
    Huguet, F.
    Cortez, A.
    Darai, E.
    Ballester, M.
    [J]. BRITISH JOURNAL OF CANCER, 2014, 110 (11) : 2640 - 2646